Literature DB >> 29066466

DGKζ deficiency protects against peripheral insulin resistance and improves energy metabolism.

Boubacar Benziane1, Melissa L Borg1, Robby Z Tom2, Isabelle Riedl2, Julie Massart2, Marie Björnholm2, Marc Gilbert2, Alexander V Chibalin2, Juleen R Zierath3,2.   

Abstract

Diacylglycerol kinases (DGKs) regulate the balance between diacylglycerol (DAG) and phosphatidic acid. DGKζ is highly abundant in skeletal muscle and induces fiber hypertrophy. We hypothesized that DGKζ influences functional and metabolic adaptations in skeletal muscle and whole-body fuel utilization. DAG content was increased in skeletal muscle and adipose tissue, but unaltered in liver of DGKζ KO mice. Linear growth, body weight, fat mass, and lean mass were reduced in DGKζ KO versus wild-type mice. Conversely, male DGKζ KO and wild-type mice displayed a similar robust increase in plantaris weight after functional overload, suggesting that DGKζ is dispensable for muscle hypertrophy. Although glucose tolerance was similar, insulin levels were reduced in high-fat diet (HFD)-fed DGKζ KO versus wild-type mice. Submaximal insulin-stimulated glucose transport and p-Akt Ser473 were increased, suggesting enhanced skeletal muscle insulin sensitivity. Energy homeostasis was altered in DGKζ KO mice, as evidenced by an elevated respiratory exchange ratio, independent of altered physical activity or food intake. In conclusion, DGKζ deficiency increases tissue DAG content and leads to modest growth retardation, reduced adiposity, and protection against insulin resistance. DGKζ plays a role in the control of growth and metabolic processes, further highlighting specialized functions of DGK isoforms in type 2 diabetes pathophysiology.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  diabetes; diacylglycerol kinase ζ; diacyl­glycerol; diet; dietary lipids; lipid kinases; muscle; obesity

Mesh:

Substances:

Year:  2017        PMID: 29066466      PMCID: PMC5711495          DOI: 10.1194/jlr.M079723

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  48 in total

1.  Molecular cloning and characterization of a novel human diacylglycerol kinase zeta.

Authors:  M Bunting; W Tang; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

Review 2.  Signaling roles of diacylglycerol kinases.

Authors:  Matthew K Topham
Journal:  J Cell Biochem       Date:  2006-02-15       Impact factor: 4.429

3.  Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes.

Authors:  Leigh Perreault; Bryan C Bergman; Devon M Hunerdosse; Robert H Eckel
Journal:  Obesity (Silver Spring)       Date:  2010-04-08       Impact factor: 5.002

4.  Skeletal muscle lipase content and activity in obesity and type 2 diabetes.

Authors:  Johan W E Jocken; Cedric Moro; Gijs H Goossens; Dominique Hansen; Aline Mairal; Matthijs K C Hesselink; Dominique Langin; Luc J C van Loon; Ellen E Blaak
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

5.  Dietary 1,3-diacylglycerol protects against diet-induced obesity and insulin resistance.

Authors:  Shinichiro Saito; Antonio Hernandez-Ono; Henry N Ginsberg
Journal:  Metabolism       Date:  2007-11       Impact factor: 8.694

6.  Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts.

Authors:  Camilla Evangelisti; Pier Luigi Tazzari; Massimo Riccio; Roberta Fiume; Yasukazu Hozumi; Federica Falà; Kaoru Goto; Lucia Manzoli; Lucio Cocco; Alberto M Martelli
Journal:  FASEB J       Date:  2007-05-08       Impact factor: 5.191

7.  Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans.

Authors:  Costas A Anastasiou; Stavros A Kavouras; Yannis Lentzas; Afrodite Gova; Labros S Sidossis; Adreas Melidonis
Journal:  Metabolism       Date:  2009-07-16       Impact factor: 8.694

8.  Enhanced T cell responses due to diacylglycerol kinase zeta deficiency.

Authors:  Xiao-Ping Zhong; Ehmonie A Hainey; Benjamin A Olenchock; Martha S Jordan; Jonathan S Maltzman; Kim E Nichols; Hao Shen; Gary A Koretzky
Journal:  Nat Immunol       Date:  2003-07-27       Impact factor: 25.606

Review 9.  Mammalian diacylglycerol kinases: molecular interactions and biological functions of selected isoforms.

Authors:  Matthew K Topham; Richard M Epand
Journal:  Biochim Biophys Acta       Date:  2009-02-06

10.  The role of diacylglycerol kinase ζ and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy.

Authors:  Jae-Sung You; Hannah C Lincoln; Chan-Ran Kim; John W Frey; Craig A Goodman; Xiao-Ping Zhong; Troy A Hornberger
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

View more
  4 in total

Review 1.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

2.  Diacylglycerol kinase α deficiency alters inflammation markers in adipose tissue in response to a high-fat diet.

Authors:  Emmani B M Nascimento; Louise Mannerås-Holm; Alexander V Chibalin; Marie Björnholm; Juleen R Zierath
Journal:  J Lipid Res       Date:  2017-12-12       Impact factor: 5.922

Review 3.  Novel Insights and Mechanisms of Lipotoxicity-Driven Insulin Resistance.

Authors:  Benjamin Lair; Claire Laurens; Bram Van Den Bosch; Cedric Moro
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

Review 4.  Beyond Lipid Signaling: Pleiotropic Effects of Diacylglycerol Kinases in Cellular Signaling.

Authors:  Jae Ang Sim; Jaehong Kim; Dongki Yang
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.